(Q33779890)

29 July 2017

1 reference

title

Dextromethorphan and diabetic neuropathy (English)

1 reference

29 July 2017

T M Criner

1

1 reference

29 July 2017

C S Perdun

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Annals of Pharmacotherapy

29 July 2017

published in

1 reference

29 July 2017

volume

33

1 reference

29 July 2017

issue

11

1 reference

29 July 2017

page(s)

1221-1223

1 reference

Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design

29 July 2017

cites work

1 reference

Dextromethorphan and levorphanol on dorsal horn nociceptive neurones in the rat

21 January 2018

1 reference

Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo

21 January 2018

1 reference

Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia

21 January 2018

1 reference

Peripheral diabetic neuropathy. Current recommendations and future prospects for its prevention and management.

21 January 2018

1 reference

The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man.

21 January 2018

1 reference

High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia

21 January 2018

1 reference

Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia

21 January 2018

1 reference

An attempt to attenuate experimental pain in humans by dextromethorphan, an NMDA receptor antagonist

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.18296

1 reference

29 July 2017

1 reference